Logan Lutton

The world’s first fixed triple therapy formula is already approved in more than 50 countries outside the United States.

In this interview, Steven Buslovich, M.D., CMD, MS, chief medical officer of senior care at PointClickCare, explains the growing role of AI in healthcare, particularly in managing patient transitions between care settings.

In this video interview, Francesca Bridge, MBBS, neurologist at Alfred Health in Melbourne, Australia, and Ph.D. candidate at Monash University, shares why the results of her latest research were reassuring, but surprising.

Some menopause symptoms may be mistaken for multiple sclerosis symptoms in older women, new research finds.

In a historical public health move, the Maldives has eliminated mother-to-child HIV, syphilis and hepatitis B, which are collectively responsible for millions of deaths annually across the globe.

Here’s what you missed this week on Managed Healthcare Executive.

More than 60 abstracts will be presented from the ViiV portfolio, including updates from the phase 1 crossover study, the first comparing the acceptability and tolerability of long acting cabotegravir and lenacapavir injections after a single dose.

Vascular endothelial growth factor (VEGF) inhibitor, Eydenzelt (aflibercept-boav), is now approved to treat retinal disease marked by excessive blood vessel growth in adults.

Emergency Medicaid spending represented only 0.4% of total Medicaid expenditures in 2022, rising to 0.9% in states with higher populations of undocumented immigrants.

Back surgeries to address age-related pain in older adults aren’t just risky, they're expensive too, according to a recent study from the Lown Institute.

In this interview, Steven Buslovich, M.D., CMD, MS, CMO of Senior Care at PointClickCare describes AI’s role in care transitions within healthcare systems and how AI can reduce readmission rates.

Older adults living with HIV face higher rates of opioid prescribing and opioid use disorder than their HIV-negative peers, according to new research from Rutgers University.

Repatha is now available for a monthly cash price of $239, through AmgenNow and GoodRx.

Three researchers have been awarded the Nobel Prize in Physiology or Medicine 2025 for the discovery of regulatory T cells, the FOXP3 gene mutation and the role they play within autoimmune diseases.

Here’s what you missed this week on Managed Healthcare Executive.

The exact cause of amyotrophic lateral sclerosis (ALS) has long remained a mystery, but new research demonstrates that there is an autoimmune component to the disease.

Menopause is not the main driver of multiple sclerosis disability progression according to a recent study published in JAMA Neurology.

Aetna has released the details of its Medicare Advantage plans for 2026, which focus on preventative care and drug cost savings.

Rhapsido is the first and only Bruton’s tyrosine kinase (BTK) inhibitor approved for chronic spontaneous urticaria (CSU).

SCAN Health Plan will expand its 2026 Medicare Advantage benefits with $0 copays and higher dental, vision and allowance coverage amid funding and coverage cuts from larger insurers such as UnitedHealthcare and Aetna.

Enrollment in Medicare Advantage Special Needs Plans (SNPs) has grown steadily since becoming permanent in 2018, now accounting for 21% of Medicare Advantage enrollees, with recent growth driven by chronic condition SNPs surpassing dual-eligible SNPs due to changing CMS requirements, according to a new KFF report.

Insulin will be available through Sanofi’s Insulins Valyou Savings Program starting January 1, 2026.

Here’s what you missed this week on Managed Healthcare Executive.

Evkeeza is now approved for the treatment of homozygous familial hypercholesterolemia (HoFH) in patients as young as 1 year old.

Tavapadon is an investigational, novel, once-daily treatment option for Parkinson’s disease, which currently affects more than 1 million Americans.

Today’s announcement builds on a previous announcement of more than 40% off the Eliquis list price, a direct-to-consumer program that began earlier this month.

Robert Gamble, CEO of RxBenefits, shares how Illuminate Rx does specialty, plus the areas they will continue to innovate on.

The FDA letter requested that a technical information update be included in the Chemistry Manufacturing and Controls (CMC) module of the sNDA.

Yael Bensoussan, M.D., director of the University of South Florida Health Voice Center, discusses menopause-related voice changes and how artificial intelligence is being used to address them.